What is the P/E ratio of Ashco Niulab Industries?

The latest standalone P/E ratio of Ashco Niulab Industries as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Ashco Niulab Industries?

The latest standalone P/B ratio of Ashco Niulab Industries as of 01-Jan-1970 is 0.03.

What is the 52-week high and low of Ashco Niulab Industries?

The 52-week high of Ashco Niulab Industries is Rs. 0.29 and the 52-week low is Rs. 0.26.

Ashco Niulab Industries Ltd - Stock Valuation and Financial Performance

Name: Ashco Niulab Industries
Brand: Ashco Niulab Industries

BSE: 517565 | NSE: ASHCONIUL | Electronics - Components | Small Cap

Place order

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Ashco Niulab Inds

Based on:

Data

M-Cap below 100cr DeciZen not available

Ashco Niulab Industries stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

1.9 Cr.

52-wk low:

0.3

52-wk high:

0.3

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Ashco Niulab Inds:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Sep'11	Mar'12	TTM
ROCE % ⓘ	7.6%	7.9%	8.2%	8.3%	2.2%	7.8%	2.3%	2.9%	-8.5%	-5.8%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	27.3	29.9	35.2	38.6	40.7	35	51.7	82.2	80.4	36.9	40
Sales YoY Gr.	-	9.9%	17.5%	9.8%	5.3%	-14%	47.8%	59%	-2.3%	-54.1%	-
Adj EPS ⓘ	0.5	0.7	0.9	1.1	-0.7	1.3	-1.4	-0.3	-1.4	-2.8	-1.5
YoY Gr.	-	38%	29%	24.7%	-159.5%	NA	-208.7%	NA	NA	NA	-
BVPS (₹) ⓘ	10.9	10.8	11.4	12.7	14.3	14.4	13.5	10.9	7.3	20.1	10.2
Adj Net Profit ⓘ	0.6	0.8	1.1	1.3	-0.8	1.5	-1.7	-1.1	-9.1	-18.2	-9
Cash Flow from Ops. ⓘ	-0.8	-0.3	-0.1	6.4	-2.6	-2.9	14.3	4.7	-25	5.8	-
Debt/CF from Ops. ⓘ	-11	-27.2	-178.6	3.1	-7.7	-9.3	2.6	7.6	-1.1	12.9	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	3.4%	-1.9%	-10.6%	-54.1%
Adj EPS ⓘ	-221.1%	NA	NA	NA
BVPSⓘ	7.1%	7.1%	14.3%	176.3%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Sep'11	Mar'12	TTM
Return on Equity % ⓘ	4.7	6.3	8	9.2	-4.9	8.8	-6.3	-3.1	-26	-13.3	-9.6
Op. Profit Mgn % ⓘ	8.2	7.1	11.6	15.5	9.6	24.3	-34	12.9	1.9	-16.3	7.7
Net Profit Mgn % ⓘ	2.2	2.8	3	3.4	-2	4.3	-3.2	-1.3	-11.4	-49.3	-23.7
Debt to Equity ⓘ	0.7	0.7	1.1	1.3	1.1	1.5	2.3	1	0.6	0.6	-
Working Cap Days ⓘ	264	251	255	229	238	379	358	272	252	2,073	329
Cash Conv. Cycle ⓘ	85	64	51	58	107	173	236	123	90	686	246

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Ashco Niulab Industries Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-1.5	-0.2
TTM Sales (₹ Cr.)	39.8	82.2
BVPS (₹.) ⓘ	10.2	13.3
Reserves (₹ Cr.) ⓘ	1	21
P/BV ⓘ	0.03	0.02
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	0.26 / 0.29
All Time Low / High (₹)	0.21 / 98.17
Market Cap (₹ Cr.)	1.9
Equity (₹ Cr.)	65
Face Value (₹)	10
Industry PE ⓘ	93.2

Management X-Ray of Ashco Niulab Inds:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

8.49

* Pledged shares as % of Promoter's holding (%)

Valuation of Ashco Niulab Inds

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Ashco Niulab Inds

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Sep'11	Mar'12
Sales	27.25	29.94	35.17	38.63	40.69	34.98	51.70	82.22	120.53	18.44
Operating Expenses ⓘ	25.01	28.11	31.11	32.65	36.78	26.50	69.52	71.63	118.26	21.45
Manufacturing Costs	0.65	1.10	1.34	1.27	0.98	1.46	2.42	2.62	6.12	2.24
Material Costs	17.18	19.75	20.38	21.61	28.56	16.17	49.26	53.06	86.10	12.24
Employee Cost	3.15	3.26	3.85	4.34	3.02	3.11	7.75	6.47	11.45	3.22
Other Costs ⓘ	4.04	3.99	5.54	5.43	4.21	5.76	10.09	9.49	14.59	3.75
Operating Profit ⓘ	2.24	1.83	4.06	5.99	3.91	8.48	-17.82	10.58	2.27	-3.01
Operating Profit Margin (%)	8.2%	6.1%	11.5%	15.5%	9.6%	24.2%	-34.5%	12.9%	1.9%	-16.3%
Other Income ⓘ	0.95	1.04	0.04	0.33	3.89	0.04	27.55	0.14	1.94	3.11
Interest ⓘ	1.51	1.32	1.44	1.85	2.27	2.32	4.25	4.51	8.61	4.11
Depreciation ⓘ	1.07	0.96	1.22	1.90	2.55	2.97	5.81	6.14	9.55	2.98
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.61	0.59	1.44	2.57	2.99	3.23	-0.33	0.08	-13.95	-6.99
Tax ⓘ	0.01	-0.03	0.38	1.03	1.08	1.72	1.05	1.12	-1.42	0
Profit After Tax	0.61	0.62	1.06	1.54	1.91	1.51	-1.38	-1.04	-12.53	-6.99
PAT Margin (%)	2.2%	2.1%	3.0%	4.0%	4.7%	4.3%	-2.7%	-1.3%	-10.4%	-37.9%
Adjusted EPS (₹)	0.5	0.5	0.9	1.3	1.6	1.3	-1.2	-0.3	-1.9	-1.1
Dividend Payout Ratio (%)	0%	0%	28%	0%	0%	79%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Sep'11	Mar'12
Equity and Liabilities
Shareholders Fund	13.09	12.98	13.70	15.25	17.17	17.27	16.21	34.09	71.05	65.44
Share Capital ⓘ	3	3	3	12	12	12	12	31.20	64.98	64.98
Reserves ⓘ	10.09	9.99	10.70	3.25	5.17	5.27	4.21	2.89	6.07	0.46
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	9.06	9.32	14.64	19.56	19.66	26.62	36.96	35.62	40.17	36.97
Long Term Debt	9.06	9.32	14.64	19.56	19.66	26.62	36.96	35.62	9.86	7.88
Short Term Debt	0	0	0	0	0	0	0	0	30.31	29.09
Trade Payables	4.39	5.09	8.97	3.55	12.40	9.33	15.64	12.91	12.09	10.46
Others Liabilities ⓘ	1.84	1.32	1.93	2.49	3.45	5.26	28.68	8.13	8.82	9.24
Total Liabilities ⓘ	28.38	28.72	39.23	40.86	52.67	58.47	97.50	90.75	132.13	122.11
Fixed Assets
Gross Block	14.21	13.92	18.56	28.10	28.98	31.49	54.16	54.36	59.82	51.29
Accumulated Depreciation	8.28	7.72	8.90	10.78	11.66	14.51	20.37	26.30	35.08	34.16
Net Fixed Assetsⓘ	5.93	6.20	9.66	17.33	17.31	16.98	33.79	28.06	24.74	17.13
CWIP ⓘ	0.34	0	0	1.15	1.49	0.14	0.16	0	0.04	0
Investmentsⓘ	0.77	0.77	0.77	0.77	0.79	0.79	0.88	0.88	0.09	0.06
Inventories	4.67	5.53	6.33	5.78	15.44	17.37	23.16	21.10	14.69	14.49
Trade Receivables	5.01	5.72	9.22	6.96	9.69	18.14	27.78	17.89	33.61	26.56
Cash Equivalents	1.07	0.67	0.78	1.12	0.52	0.51	1.17	0.72	1.81	0.89
Others Assetsⓘ	10.60	9.83	12.48	7.76	7.42	4.53	10.56	22.11	57.15	62.97
Total Assets ⓘ	28.38	28.72	39.23	40.86	52.67	58.47	97.50	90.75	132.13	122.11

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Sep'11	Mar'12
Cash Flow From Operating Activity ⓘ	-0.82	-0.34	-0.08	6.35	-2.56	-2.86	14.25	4.68	-37.42	2.88
PBT ⓘ	0.61	0.59	1.44	2.57	2.99	3.23	-0.33	0.08	-13.95	-6.99
Adjustment ⓘ	1.67	1.55	2.66	3.73	0.93	5.15	8.94	10.34	15.69	9.65
Changes in Working Capital ⓘ	-1.1	-1.23	-3.07	3.11	-5.37	-8.55	7.26	-4.12	-37.3	0.22
Tax Paid ⓘ	-0.50	0.08	0.33	-1.21	-0.36	-1.14	-1.62	-1.62	-1.87	0
Cash Flow From Investing Activity ⓘ	0.43	-0.11	-4.64	-10.70	0.99	-1.24	-5.59	-0.17	-3.73	3.08
Capex	-0.50	-1.15	-4.65	-10.72	0.99	-1.27	-5.65	-0.21	-5.16	3
Net Investments	0	0	0	0	-0.03	0	0	0	1.27	0.02
Others ⓘ	0.94	1.04	0.01	0.02	0.02	0.03	0.06	0.04	0.17	0.06
Cash Flow From Financing Activityⓘ	0.38	0.06	4.83	4.69	0.97	4.07	-9.54	-4.96	42.25	-4.93
Net Proceeds from Shares ⓘ	0	0	0	0.01	0	0	0	0	45.60	0
Net Proceeds from Borrowing ⓘ	-0.44	-0.19	-0.31	-0.45	-3.61	-10.26	0	0	0	0
Interest Paid ⓘ	0	0	0	0	-1.51	-0.68	-3.80	-4.28	-7.90	-3.72
Dividend Paid ⓘ	0	0	0	0	0	-1.17	0	0	0	0
Others ⓘ	0.82	0.25	5.14	5.12	6.09	16.18	-5.73	-0.68	4.55	-1.21
Net Cash Flow ⓘ	-0.01	-0.39	0.11	0.33	-0.60	-0.03	-0.88	-0.45	1.09	1.03

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Sep'11	Mar'12
Ratios
ROE (%)	4.77	4.75	7.92	10.66	11.81	8.79	-8.24	-4.13	-23.83	-10.25
ROCE (%)	9.79	8.63	11.36	13.99	14.68	13.75	6.75	6.45	-5.9	-2.7
Asset Turnover Ratio	0.97	1.05	1.04	0.96	0.87	0.63	0.66	0.87	1.08	0.15
PAT to CFO Conversion(x)	-1.34	-0.55	-0.08	4.12	-1.34	-1.89	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	81	65	78	76	75	145	162	101	78	595
Inventory Days	60	62	62	57	95	171	143	98	54	289
Payable Days	79	88	126	106	102	245	93	98	53	336

Ashco Niulab Industries Ltd Stock News

Ashco Niulab Industries Ltd FAQs

What is the share price of Ashco Niulab Inds?

Company share prices are keep on changing according to the market conditions. The closing price of Ashco Niulab Inds on 01-Jan-1970 05:30 is ₹0.00.

What is the market cap of Ashco Niulab Inds?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Ashco Niulab Inds stood at ₹1.88.

What is the P/E ratio of Ashco Niulab Inds?

The latest P/E ratio of Ashco Niulab Inds as of 01-Jan-1970 05:30 is 0.00.

What is the P/B ratio of Ashco Niulab Inds?

The latest P/B ratio of Ashco Niulab Inds as of 01-Jan-1970 05:30 is 0.03.

What is the 52-week high and low of Ashco Niulab Inds?

The 52-week high of Ashco Niulab Inds is ₹0.29 and the 52-week low is ₹0.26.

What is the TTM revenue of Ashco Niulab Inds?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ashco Niulab Inds is ₹39.77 ( Cr.) .

About Ashco Niulab Industries Ltd

Ashco Niulab Industries incorporated in the year 1986. Ashok K. Kotwani initiated the first company of the group, Niulab Equipment Company Pvt Ltd. in 1982, followed by Ashco industries Ltd. in 1986 and now renamed as Ashco Niulab Industries Ltd. From a small beginning, today the group has more than 250 employees and national presence with corporate headquarters in Mumbai, 14 branches, 4 laboratories and an office in USA. The companyâ€™s corporate office is located at Lab House, Plot No F - 13, Opp. Seepz, Andheri E Mumbai, Maharashtra-400093 .

The company provides services to all major pharmaceuticals and FMCG companies. For international business the company is focusing in US, Europe, Latin America and other overseas markets. In order to facilitate US operations the company has office in New Jersey. The company provides with the services of Contract Research (BA/BE), Analytical Services, Process Safety Lab and Instrumentation.

Contract Research (BA/BE) - Spread over 20,000 sq.ft, the company provides contract research services in areas of bioavailability and bioequivalence studies. It delivers cost effective, timely research solutions to the Pharmaceutical and Biotechnology companiesâ€™ world wide. It offers its clients significant value addition that includes quicker subject/special population recruitment, quality assurance and competitive cost.

Analytical Services - In the technologically advance times of today, leading edge R & D is a pre-condition to success. Various manufacturing organizations require Analytical solutions which need the outsourced support of sophisticated equipment and skilled professionals, to develop new products or for quality checks. The company provides support to organizations through state-of-art infrastructure and well qualified and experienced professionals. The company is already providing analytical solutions to various industries like pharmaceuticals, food and environmental studies. The company strives to provide quality services at all times to their esteemed clientele through their team of dedicated professionals. Three strategically located laboratories at Mumbai, Noida and Hyderbad, enable it to cater to the analytic needs across the country. The companyâ€™s laboratories are accredited by NABL, local FDAs, DGCA and ISO.

Process Safety Lab - The company provide solutions to the industry for process optimisation and process safety. Ashco Niulab Industries provides solutions to pharma and chemical industries. The company will be installing Reaction Calorimeter and Thermal Scanning Calorimeter to provide right solution. To the industry Ashco Niulab Industries will also organize training on process safety and product safety.

Instrumentation - The companyâ€™s instrumentation division provides solutions to industry for Pharma Chemical R & D, & Quality control. From their principals from Switzerland, France, Japan, USA.